Results 11 to 20 of about 8,070 (126)

Multivalvular Carcinoid Heart Disease: The Role of Echocardiography in Diagnosis and Selection for Heterotopic Bicaval Valve Implantation [PDF]

Diagnostics
Background and Clinical Significance: Carcinoid heart disease (CHD) is an uncommon valvular manifestation of neuroendocrine tumours, usually affecting right-sided cardiac valves.
Bianca Corrêa Rocha de Mello, Ana Clara Pierote Rodrigues Vasconcelos, Mariana Ubaldo Barbosa Paiva, Mateus Veloso e Silva, Nattália de Oliveira Maciel, Priscila Ribeiro de Andrade, Rodolfo Deusdará, Maria Estefânia Bosco Otto   +7 more
doaj   +2 more sources

Transcatheter tricuspid valve interventions: Current status and future perspectives

Frontiers in Cardiovascular Medicine, 2022
The development of transcatheter therapies to treat valvular heart diseases has changed the rules of the game, particularly in the case of aortic stenosis and mitral regurgitation.
Alberto Alperi, Alberto Alperi, Marcel Almendárez, Marcel Almendárez, Rut Álvarez, Rut Álvarez, Cesar Moris, Cesar Moris, Cesar Moris, Victor Leon, Victor Leon, Iria Silva, Iria Silva, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Isaac Pascual, Isaac Pascual, Isaac Pascual, Pablo Avanzas, Pablo Avanzas, Pablo Avanzas   +21 more
doaj   +1 more source

Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation

US Cardiology Review, 2021
Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical intervention for isolated tricuspid regurgitation (TR) was avoided despite the prevalence of TR, largely due to poor surgical outcomes and an incomplete ...
Kusha Rahgozar, Sharon Bruoha, Edwin Ho, Ythan Goldberg, Mei Chau, Azeem Latib   +5 more
doaj   +1 more source

Surgical outcomes of patients at prohibitive risk who are reconsidered for surgeryCentral MessagePerspective

JTCVS Open, 2023
Objectives: Transcatheter treatment of advanced mitral and tricuspid valve disease is largely limited to patients at prohibitive surgical risk, although many are not candidates for transcatheter treatment.
Catherine M. Wagner, MD, Megan L. Schultz, MD, Alexander A. Brescia, MD, MSc, Yoyo Wang, BS, Whitney Fu, MD, Robert B. Hawkins, MD, MSc, Matthew A. Romano, MD, Gorav Ailawadi, MD, MBA, Steven F. Bolling, MD   +8 more
doaj   +1 more source

A Systematic Review of the Design, Method of Implantation and Early Clinical Outcomes of Transcatheter Tricuspid Prostheses

Reviews in Cardiovascular Medicine, 2023
Background: Intervention for tricuspid regurgitation (TR) tends to happen concurrently with and is addressed during mitral valve surgery. Isolated TR interventions, however, are not unusual and are becoming more common.
Faizus Sazzad, Yinling Zhu, Hwa Liang Leo, Jie Hui Nah, Hui Ying Ang, Chuen Neng Lee, Jimmy Kim Fatt Hon   +6 more
doaj   +1 more source

Multi-Modality Imaging of the Tricuspid Valve: From Tricuspid Valve Disease to Catheter-Based Interventions

Reviews in Cardiovascular Medicine, 2022
Tricuspid valve disease represents a major health problem that affects a wide proportion of heart failure patients with a significant prognostic impact.
Fabio Fazzari, Francesco Cannata, Matteo Maurina, Renato Maria Bragato, Marco Francone   +4 more
doaj   +1 more source

2022 CMICS Expert Consensus on the Management of Isolated Tricuspid Regurgitation after Left-Sided Valve Surgery

Reviews in Cardiovascular Medicine, 2023
Tricuspid regurgitation (TR) may occur late after left-sided valve surgery (LSVS). Isolated tricuspid regurgitation after left-sided valve surgery (iTR-LSVS) refers to isolated TR without significant lesions in the mitral and/or aortic position late ...
Jinmiao Chen, Zhaoyun Cheng, Nianguo Dong, Lili Dong, Huiming Guo, Yingqiang Guo, Huanlei Huang, Shengli Jiang, Fanglin Lu, Fei Li, Jinping Liu, Liming Liu, Xin Li, Ju Mei, Liang Ma, Chenhui Qiao, Lizhong Sun, Guowei Tu, Liang Tao, Dongjin Wang, Huishan Wang, Minxin Wei, Song Wan, Jianjun Xu, Song Xue, Zhe Zheng, Lai Wei, Chunsheng Wang, on behalf of CMICS   +28 more
doaj   +1 more source

Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR).
Wang Wei, Li Ning, Li Ning, Ning Xiaoping, Xu Zhiyun, Li Bailing, Cai Chengliang, Yang Fan, Zhou Guangwei, Bai Yifan, Han Lin, Qiao Fan, Lu Fanglin   +12 more
doaj   +1 more source

Real-Time Monitoring and Step-by-Step Guidance for Transcatheter Tricuspid Annuloplasty Using Transesophageal Echocardiography

Journal of Cardiovascular Development and Disease, 2022
Transcatheter tricuspid valve intervention (TTVI) is a novel alternative to functional tricuspid regurgitation (FTR) for patients with prohibitive surgical risk.
Yu Liu, Wei Li, Daxin Zhou, Xiaochun Zhang, Dehong Kong, Zhenyi Ge, Haiyan Chen, Xianhong Shu, Cuizhen Pan, Junbo Ge   +9 more
doaj   +1 more source

Valve-in-Ring Transcatheter Heart Valve for Severe Tricuspid Regurgitation

JACC: Case Reports, 2019
We report the case of a man with recurrent decompensated right-sided heart failure secondary to severe tricuspid regurgitation after tricuspid annuloplasty.
Leigh A. Cummins, MBBS, Gita Mathur, BSc, MBBS, Nigel S. Jepson, MBBS, Virag V. Kushwaha, BSc, MBBS, PhD   +3 more
doaj   +1 more source